Megval 50mg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Melphalan (50mg)
Overview Megval 50mg Injection
Oncaspar 50mg Injection, an anticancer medication, treats ovarian cancer and multiple myeloma (a bone marrow cancer). Its use may extend to other conditions as directed by your physician. Administered intravenously by a healthcare professional, self-injection is strictly prohibited. Dosage and frequency, determined by your doctor, are tailored to your condition and may adjust over time. Therapeutic effects might not be immediately apparent; continued use is crucial unless your doctor advises otherwise. Increased sun sensitivity necessitates protective clothing and sunscreen. Common side effects encompass nausea, vomiting, anemia, and hair loss. Reduced blood cell counts increase infection risk, mandating regular blood tests to monitor blood cell levels, kidney, liver, and heart function. Report any infection signs (fever, chills, aches), unusual bleeding (bruising, bleeding gums, hematuria, melena) to your doctor immediately. Prior to treatment, disclose any bleeding disorders, liver or kidney issues, or concurrent use of anti-infectives. Interaction with other medications is possible; inform your doctor of all medications. Avoid use during pregnancy or breastfeeding. Effective contraception for both partners is essential throughout the treatment period.
Primary Ingredients of Megval 50mg Injection
No text provided to rephrase.
Uses of Megval 50mg Injection
Myeloma and ovarian malignancies
Major Benefits of Megval 50mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Megval 50mg Injection:
- Hair loss
- Low blood platelets
- Diarrhea
- Decreased white blood cell count
- Nausea
- Vomiting
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
How to use Megval 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Megval 50mg Injection works:
Oncaspar 50mg injection is a cancer treatment that disrupts the genetic makeup (DNA and RNA) of malignant cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Megval 50mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Megval 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Megval 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCONSULT YOUR DOCTOR
Megval 50mg Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, administering Megval 50mg Injection requires careful consideration. Dosage modification of Megval 50mg Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Megval 50mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Megval 50mg Injection :
Omitting a scheduled dose of Megval 50mg Injection necessitates contacting your physician. Regular dosing is crucial.
Facts to Know About Megval 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Alkylating Agents (Nitrogen Mustard Class) |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
3,018 People bought this recently